Results 61 to 70 of about 4,356 (97)
Some of the next articles are maybe not open access.
JAMA: The Journal of the American Medical Association, 1979
To the Editor.— The Journalis to be congratulated for publication of the article on timolol maleate (241:2301, 1979). At the Wills Eye Hospital, we have had considerable experience in the investigational and clinical use of timolol. We believe a few comments should be added to Dr Kosman's review.
George L Spaeth, Richard P. Wilson
openaire +3 more sources
To the Editor.— The Journalis to be congratulated for publication of the article on timolol maleate (241:2301, 1979). At the Wills Eye Hospital, we have had considerable experience in the investigational and clinical use of timolol. We believe a few comments should be added to Dr Kosman's review.
George L Spaeth, Richard P. Wilson
openaire +3 more sources
Acta Ophthalmologica, 1986
Abstract The influence of timolol on the corneal epithelium and endothelium was studied in organ culture. The cell morphology was not influenced by drug concentrations ≦ 690 μg/ml. Cell death was observed at 6900 μg/ml. Endothelial cell proliferation after an experimental injury was slowed down at a drug concentration of 690 μg/ml.
Martin Davanger, Erling Grøvold Olsen
openaire +3 more sources
Abstract The influence of timolol on the corneal epithelium and endothelium was studied in organ culture. The cell morphology was not influenced by drug concentrations ≦ 690 μg/ml. Cell death was observed at 6900 μg/ml. Endothelial cell proliferation after an experimental injury was slowed down at a drug concentration of 690 μg/ml.
Martin Davanger, Erling Grøvold Olsen
openaire +3 more sources
Archives of Ophthalmology, 1989
To the Editor. —In the July 1988 issue of theArchives, Lynch et al 1 reported on 18 patients with central nervous system (CNS) effects during timolol maleate therapy whose condition improved after switching to betaxolol hydrochloride therapy. Unfortunately, however, they did not report on the intraocular pressure.
Jelle de Vries +2 more
openaire +3 more sources
To the Editor. —In the July 1988 issue of theArchives, Lynch et al 1 reported on 18 patients with central nervous system (CNS) effects during timolol maleate therapy whose condition improved after switching to betaxolol hydrochloride therapy. Unfortunately, however, they did not report on the intraocular pressure.
Jelle de Vries +2 more
openaire +3 more sources
Timolol in Migraine Prophylaxis
Headache: The Journal of Head and Face Pain, 1979SYNOPSISThe literature on the use of beta‐blocking drugs in migraine suggests that not all such agents are effective. A double‐blind crossover study of timolol in migraine prophylaxis was undertaken with fourteen patients, in order to assess the value of this drug in particular, and also to elucidate further the reason for the varied response to ...
Briggs, R S, Millac, P A
openaire +4 more sources
Ophthalmology, 1981
This collaborative study involves 39 investigators and shows the effects of timolol maleate when used short-term on large numbers of patients (418). Intraocular pressure response is excellent. Statistical analyses of pressure response are done using random sampling.
Gordon Krip, Raymond P. LeBlanc
openaire +3 more sources
This collaborative study involves 39 investigators and shows the effects of timolol maleate when used short-term on large numbers of patients (418). Intraocular pressure response is excellent. Statistical analyses of pressure response are done using random sampling.
Gordon Krip, Raymond P. LeBlanc
openaire +3 more sources
Survey of Ophthalmology, 1979
Of 145 patients registered for an investigation of timolol, 27 patients were dropped for unrelated reasons. Among the remaining 118 patients (212 eyes), a significant reduction in intraocular pressure resulted from twice-a-day topical instillation of 0.25 or 0.5% timolol to ocular hypertensives, primary open-angle glaucoma or aphakic glaucoma patients.
Luke-Long Lin +7 more
openaire +3 more sources
Of 145 patients registered for an investigation of timolol, 27 patients were dropped for unrelated reasons. Among the remaining 118 patients (212 eyes), a significant reduction in intraocular pressure resulted from twice-a-day topical instillation of 0.25 or 0.5% timolol to ocular hypertensives, primary open-angle glaucoma or aphakic glaucoma patients.
Luke-Long Lin +7 more
openaire +3 more sources
Timolol and Pediatric Glaucomas
Ophthalmology, 1981Thirty-eight eyes were treated by adding timolol to the medical regimen. After a suitable trial, attempts were made to reduce other glaucoma medications. Fifteen eyes with infantile glaucoma treated surgically at birth, experienced elevated intraocular pressure later in life.
Robert N. Shaffer +3 more
openaire +3 more sources
Survey of Ophthalmology, 1983
Timolol maleate, a nonselective beta blocker, has been associated with adverse reactions when administered topically or systemically. The current literature pertaining to timolol-related side effects and reports to the National Registry of Drug Induced Ocular Side Effects are reviewed.
Thom J. Zimmerman +2 more
openaire +3 more sources
Timolol maleate, a nonselective beta blocker, has been associated with adverse reactions when administered topically or systemically. The current literature pertaining to timolol-related side effects and reports to the National Registry of Drug Induced Ocular Side Effects are reviewed.
Thom J. Zimmerman +2 more
openaire +3 more sources
Survey of Ophthalmology, 1983
In determining the role of timolol in the treatment of childhood glaucoma, the difficulties of conducting investigational studies in children and the possible delayed appearance of longterm side effects are real concerns. However, an equally important consideration is the fact that young children may face a lifetime of blindness from uncontrolled ...
William P. Boger, William P. Boger
openaire +2 more sources
In determining the role of timolol in the treatment of childhood glaucoma, the difficulties of conducting investigational studies in children and the possible delayed appearance of longterm side effects are real concerns. However, an equally important consideration is the fact that young children may face a lifetime of blindness from uncontrolled ...
William P. Boger, William P. Boger
openaire +2 more sources
GLAUCOMA TREATMENT WITH TIMOLOL
Acta Ophthalmologica, 1978Thirty‐two eyes from 19 patients with either capsular glaucoma, pigmentary glaucoma or primary open angle glaucoma were given topical timolol and followed through a 3–6 months period.Twelve eyes were previously out of control on full medication including pilocarpine, epinephrine and acetazolamide.
Emilia Kerty, Ivar Hørven
openaire +3 more sources